News Isofol Medical AB

Equities

ISOFOL

SE0009581051

Market Closed - Nasdaq Stockholm Other stock markets 11:22:30 2024-04-24 am EDT			5-day change	1st Jan Change
0.692 ^SEK	-0.86%		+6.46%	-5.21%

Feb. 20	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 20	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023	Apr. 16	AQ
Notice to attend the Annual General Meeting held on May 8, 2024 in Isofol Medical AB (publ)	Apr. 05	AQ
Isofol Medical : Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	Mar. 19	PU
Isofol’s Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	Mar. 19	AQ
Isofol presents a clinical development plan for arfolitixorin	Mar. 19	AQ
Isofol Medical : invites to investor meeting on March 19	Mar. 01	PU
Isofol Medical AB (publ) publishes year-end report, January - December 2023	Feb. 20	AQ
Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Isofol's Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19	Feb. 14	AQ
Isofol Medical Hires New CFO	Jan. 11	MT
Isofol appoints Magnus Hurst as new Chief Financial Officer	Jan. 10	AQ
Isofol Medical AB Announces Chief Financial Officer Changes	Jan. 10	CI
Isofol Medical Names New CEO	Jan. 09	MT
Isofol appoints Petter Segelman Lindqvist as new CEO	Jan. 09	AQ
Isofol Medical AB Announces CEO Changes	Jan. 09	CI
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on January 4, 2024	Jan. 04	AQ
Isofol Medical AB Announces Board Elections	Jan. 04	CI
Isofol presents additional results from laboratory tests with arfolitixorin showing supplementary effects	Dec. 28	AQ
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	Dec. 28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Isofol Medical AB

Equities

ISOFOL

SE0009581051

Summary

Filters